What effect does RAAS activation have on the kidney, and how do ACE inhibitors alter this?

Prepare thoroughly for the Genitourinary System Disorders Test. Explore flashcards and multiple choice questions with explanations. Enhance your readiness for the examination!

Multiple Choice

What effect does RAAS activation have on the kidney, and how do ACE inhibitors alter this?

Explanation:
RAAS activation raises angiotensin II, which constricts the efferent arteriole of the glomerulus. This raises intraglomerular pressure, increasing filtration pressure and, over time, promoting proteinuria and fibrotic changes in the kidney. ACE inhibitors block the formation of angiotensin II, causing efferent arteriole dilation and a drop in intraglomerular pressure. The result is less protein leakage, and reduced fibrotic remodeling, which slows progression of kidney disease.

RAAS activation raises angiotensin II, which constricts the efferent arteriole of the glomerulus. This raises intraglomerular pressure, increasing filtration pressure and, over time, promoting proteinuria and fibrotic changes in the kidney. ACE inhibitors block the formation of angiotensin II, causing efferent arteriole dilation and a drop in intraglomerular pressure. The result is less protein leakage, and reduced fibrotic remodeling, which slows progression of kidney disease.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy